Literature DB >> 31144208

Toll-Like Receptors, Infections, and Rheumatoid Arthritis.

Marina I Arleevskaya1, R V Larionova1, Wesley H Brooks2, Eléonore Bettacchioli3, Yves Renaudineau4,5.   

Abstract

Toll-like receptors (TLR) that belong to the group of protein recognition receptor (PPR) provide an innate immune response following the sensing of conserved pathogen-associated microbial patterns (PAMPs) and changes in danger-associated molecular patterns (DAMPs) that are generated as a consequence of cellular injury. Analysis of the TLR pathway has moreover offered new insights into the pathogenesis of rheumatoid arthritis (RA). Indeed, a dysfunctional TLR-mediated response characterizes RA patients and participates in establishment of a chronic inflammatory state. Such an inappropriate TLR response has been attributed (i) to the report of important alterations in the microbiota and abnormal responses to infectious agents as part of RA; (ii) to the abnormal presence of TLR-ligands in the serum and synovial fluid of RA patients; (iii) to the overexpression of TLR molecules; (iv) to the production of a large panel of pro-inflammatory cytokines downstream of the TLR pathway; and (v) to genetic variants and epigenetic factors in susceptible RA patients promoting a hyper TLR response. As a consequence, the development of promising therapeutic strategies targeting TLRs for the treatment and prevention of RA is emerging.

Entities:  

Keywords:  Infections; Rheumatoid arthritis; Toll-like receptors

Year:  2020        PMID: 31144208     DOI: 10.1007/s12016-019-08742-z

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  72 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

2.  Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis.

Authors:  Ted R Mikuls; Jeffrey B Payne; Fang Yu; Geoffrey M Thiele; Richard J Reynolds; Grant W Cannon; Jeffrey Markt; David McGowan; Gail S Kerr; Robert S Redman; Andreas Reimold; Garth Griffiths; Mark Beatty; Shawneen M Gonzalez; Debra A Bergman; Bartlett C Hamilton; Alan R Erickson; Jeremy Sokolove; William H Robinson; Clay Walker; Fatiha Chandad; James R O'Dell
Journal:  Arthritis Rheumatol       Date:  2014-05       Impact factor: 10.995

3.  CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.

Authors:  Rajesh Rajaiah; Darren J Perkins; Derek D C Ireland; Stefanie N Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-23       Impact factor: 11.205

4.  Memory B Cells and Response to Abatacept in Rheumatoid Arthritis.

Authors:  Pierre Gazeau; Guillermo Carvajal Alegria; Valérie Devauchelle-Pensec; Christophe Jamin; Julie Lemerle; Boutahar Bendaoud; Wesley H Brooks; Alain Saraux; Divi Cornec; Yves Renaudineau
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

5.  Porphyromonas gingivalis infection exacerbates the onset of rheumatoid arthritis in SKG mice.

Authors:  M Yamakawa; K Ouhara; M Kajiya; S Munenaga; M Kittaka; S Yamasaki; K Takeda; K Takeshita; N Mizuno; T Fujita; E Sugiyama; H Kurihara
Journal:  Clin Exp Immunol       Date:  2016-08-29       Impact factor: 4.330

Review 6.  The family of the interleukin-1 receptors.

Authors:  Diana Boraschi; Paola Italiani; Sabrina Weil; Michael U Martin
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

Review 7.  Rheumatoid arthritis.

Authors:  Josef S Smolen; Daniel Aletaha; Anne Barton; Gerd R Burmester; Paul Emery; Gary S Firestein; Arthur Kavanaugh; Iain B McInnes; Daniel H Solomon; Vibeke Strand; Kazuhiko Yamamoto
Journal:  Nat Rev Dis Primers       Date:  2018-02-08       Impact factor: 52.329

8.  MiR-140-5p inhibits synovial fibroblasts proliferation and inflammatory cytokines secretion through targeting TLR4.

Authors:  Hui Li; Shi-Bing Guan; Yi Lu; Fei Wang
Journal:  Biomed Pharmacother       Date:  2017-10-06       Impact factor: 6.529

9.  Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling.

Authors:  Sam Strickson; Christoph H Emmerich; Eddy T H Goh; Jiazhen Zhang; Ian R Kelsall; Thomas Macartney; C James Hastie; Axel Knebel; Mark Peggie; Francesco Marchesi; J Simon C Arthur; Philip Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-12       Impact factor: 11.205

10.  Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.

Authors:  Anne-Marie Quirke; Elena Birgitta Lugli; Natalia Wegner; Bart C Hamilton; Peter Charles; Muslima Chowdhury; A Jimmy Ytterberg; Roman A Zubarev; Jan Potempa; Shauna Culshaw; Yonghua Guo; Benjamin A Fisher; Geoffrey Thiele; Ted R Mikuls; Patrick Jw Venables
Journal:  Ann Rheum Dis       Date:  2013-03-05       Impact factor: 19.103

View more
  13 in total

1.  Computation-Based Discovery of Potential Targets for Rheumatoid Arthritis and Related Molecular Screening and Mechanism Analysis of Traditional Chinese Medicine.

Authors:  Jijia Sun; Baocheng Liu; Ruirui Wang; Ying Yuan; Jianying Wang; Lei Zhang
Journal:  Dis Markers       Date:  2022-06-04       Impact factor: 3.464

2.  Polyene Phosphatidylcholine Interacting with TLR-2 Prevents the Synovial Inflammation via Inactivation of MAPK and NF-κB Pathways.

Authors:  Zixuan Xu; Wenting Hao; Daxiang Xu; Yan He; Ziyi Yan; Fenfen Sun; Xiangyang Li; Xiaoying Yang; Yinghua Yu; Renxian Tang; Kuiyang Zheng; Wei Pan
Journal:  Inflammation       Date:  2022-02-02       Impact factor: 4.092

3.  Suppression of inflammatory arthritis by the parasitic worm product ES-62 is associated with epigenetic changes in synovial fibroblasts.

Authors:  Marlene Corbet; Miguel A Pineda; Kun Yang; Anuradha Tarafdar; Sarah McGrath; Rinako Nakagawa; Felicity E Lumb; Colin J Suckling; William Harnett; Margaret M Harnett
Journal:  PLoS Pathog       Date:  2021-11-08       Impact factor: 6.823

Review 4.  Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems.

Authors:  Haixia Li; Shan Liu; Jinming Han; Shengxian Li; Xiaoyan Gao; Meng Wang; Jie Zhu; Tao Jin
Journal:  Front Immunol       Date:  2021-11-01       Impact factor: 7.561

5.  The Expression of Inflammasomes NLRP1 and NLRP3, Toll-Like Receptors, and Vitamin D Receptor in Synovial Fibroblasts From Patients With Different Types of Knee Arthritis.

Authors:  Regina Sakalyte; Jaroslav Denkovskij; Eiva Bernotiene; Sigita Stropuviene; Silvija Ona Mikulenaite; Giedrius Kvederas; Narunas Porvaneckas; Vytautas Tutkus; Algirdas Venalis; Irena Butrimiene
Journal:  Front Immunol       Date:  2022-01-19       Impact factor: 7.561

6.  RA Fibroblast-Like Synoviocytes Derived Extracellular Vesicles Promote Angiogenesis by miRNA-1972 Targeting p53/mTOR Signaling in Vascular Endotheliocyte.

Authors:  Yixiong Chen; Junlong Dang; Xiaorong Lin; Manli Wang; Yan Liu; Jingrong Chen; Ye Chen; Xiqing Luo; Zuoyu Hu; Weizhen Weng; Xiaoyi Shi; Xuan Bi; Yan Lu; Yunfeng Pan
Journal:  Front Immunol       Date:  2022-03-08       Impact factor: 7.561

7.  Identification of the Association Between Toll-Like Receptors and T-Cell Activation in Takayasu's Arteritis.

Authors:  Yixiao Tian; Biqing Huang; Jing Li; Xinping Tian; Xiaofeng Zeng
Journal:  Front Immunol       Date:  2022-01-20       Impact factor: 7.561

8.  SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases.

Authors:  Regina Larionova; K Byvaltsev; Оlga Kravtsova; Elena Takha; Sergei Petrov; Gevorg Kazarian; Anna Valeeva; Eduard Shuralev; Malik Mukminov; Yves Renaudineau; Marina Arleevskaya
Journal:  J Transl Autoimmun       Date:  2022-04-12

Review 9.  Toll-Like Receptors: General Molecular and Structural Biology.

Authors:  Payam Behzadi; Herney Andrés García-Perdomo; Tomasz M Karpiński
Journal:  J Immunol Res       Date:  2021-05-29       Impact factor: 4.818

10.  NLRP3 inflammasome activation contributes to development of alopecia areata in C3H/HeJ mice.

Authors:  Kei Hashimoto; Yoshihito Yamada; Kota Sekiguchi; Sachi Mori; Tatsumi Matsumoto
Journal:  Exp Dermatol       Date:  2021-07-26       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.